Compare GFR & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GFR | USBC |
|---|---|---|
| Founded | 2018 | N/A |
| Country | Canada | |
| Employees | N/A | 6 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 409.7M | 333.2M |
| IPO Year | N/A | N/A |
| Metric | GFR | USBC |
|---|---|---|
| Price | $4.73 | $0.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 231.7K | N/A |
| Earning Date | 11-03-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 252.40 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $470,838,329.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.81 | N/A |
| 52 Week High | $7.38 | N/A |
| Indicator | GFR | USBC |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 43.84 |
| Support Level | $4.60 | $0.73 |
| Resistance Level | $5.35 | $0.91 |
| Average True Range (ATR) | 0.27 | 0.08 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 28.57 | 26.18 |
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.
USBC Inc is a non-invasive medical diagnostics. The group is focused on the development and commercialization of proprietary sensor technology utilizing radio and microwave dielectric spectroscopy. Its Sensor technology elicits a dielectric response that is different for every molecule. The group considers the business to currently have one operating segment: the development of its radio frequency spectroscopy technology, with a first focus on non-invasively ascertaining blood glucose levels.